论文著作、科研成果及荣誉 |
1. Li H1, Ji S1, Ariefta NR, Galon EMS, El-Sayed SAES, Do T, Jia L, Sakaguchi M, Asada M, Nishikawa Y, Qin X, Liu M, Xuan X. Efficacy and mechanism of action of cipargamin as an antibabesial drug candidate. Elife, 2025. 2. Cao S1, Zhou M1, Ji S1, Ma D, Zhu S. Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines. Pathogens, 2024. 3. Cao S1, Ma D1, Ji S1, Zhou M, Zhu S. Self-Assembled Ferritin Nanoparticles for Delivery of Antigens and Development of Vaccines: From Structure and Property to Applications. Molecules, 2024. 4. Ma D, Sekiguchi K, Galon EM, Liu M, Ji S*, Xuan X*. Evaluation of the inhibitory effects of sitamaquine on Babesia infections. Parasitol Int. 2024. 5. Ji, S., Rizk, M. A., Galon, E. M., El-Alfy, E. S., Mizukawa, Y., Kojima, M., Ikegami-Kawai, M., Kaya, M., Liu, M., Itoh, I., & Xuan, X. Anti-babesial activity of a series of 6,7-dimethoxyquinazoline-2,4 diamines (DMQDAs). Acta tropica, 2023. 6. Ji S, Galon EM, Amer MM, Zafar I, Yanagawa M, Asada M, Zhou J, Liu M, Xuan X. Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts. Front Cell Infect Microbiol, 2022. 7. Ji S, Galon EM, Rizk MA, Yi Y, Zafar I, Li H, Ma Z, Iguchi A, Asada M, Liu M, Xuan X. Efficacy of the antimalarial MMV390048 against Babesia infection reveals phosphatidylinositol 4-kinase as a druggable target for babesiosis. Antimicrob Agents Chemother, 2022. 8. Ji S1, Ceylan O1, Ma Z1, Galon EM, Zafar I, Li H, Hasegawa Y, Sevinc M, Masatani T, Iguchi A, Kawase O, Umemiya-Shirafuji R, Asada M, Sevinc F, Xuan X. Protozoan and rickettsial pathogens in ticks collected from infested cattle from Turkey. Pathogens, 2022. 9. Ji S, Liu M, Galon EM, Rizk MA, Tuvshintulga B, Li J, Zafar I, Hasegawa Y, Iguchi A, Yokoyama N, Xuan X. Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo. Parasit Vectors, 2022. 10. Ji S, Liu M, Galon EM, Rizk MA, Li J, Li Y, Zafar I, Igarashi I, Xuan X. In vitro screening of novel anti Babesia gibsoni drugs from natural products. Parasitol Int,2021. 11. Ji S, Luo Y, Zhang T, Shao L, Meng XY, Wang Y, Gao Y, Li Y, Li S, Sun Y, Jin X, Qiu HJ. An improved indirect ELISA for specific detection of antibodies against classical swine fever virus based on structurally. designed E2 protein expressed in suspension mammalian cells. Arch Virol, 2018. 12. Luo Y1, Ji S1, Liu Y1, Lei JL, Xia SL, Wang Y, Du ML, Shao L, Meng XY, Zhou M, Sun Y, Qiu HJ. Isolation and characterization of a moderately virulent classical swine fever virus emerging in China. Transbound Emerg Dis, 2017. 13. Luo Y1, Ji S1, Lei JL1, Xiang GT, Liu Y, Gao Y, Meng XY, Zheng G, Zhang EY, Wang Y, Du ML, Li Y, Li S, He XJ, Sun Y, Qiu HJ. Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China. Vet Microbiol, 2017. 主要荣誉 青年图们江学者B类（2024） 日本兽医寄生虫学会青年学者奖 （2023） |
